Literature DB >> 1910010

Host defense against cholera toxin is strongly CD4+ T cell dependent.

E Hörnqvist1, T J Goldschmidt, R Holmdahl, N Lycke.   

Abstract

This study investigates the role of CD4+ T cells in host defense against cholera enterotoxin-induced diarrhea. Antitoxin immunoglobulin A formation and gut protection against cholera toxin (CT) following oral immunizations with CT were evaluated in normal mice and mice that had been depleted of CD4+ T cells by in vivo treatment with specific anti-CD4 monoclonal antibodies. Flow cytometer analysis demonstrated that anti-CD4 monoclonal antibody effectively eliminated CD4+ T cells in the spleen, mesenteric lymph nodes, and Peyer's patches. In contrast, lamina propria lymphocytes demonstrated only some decrease in CD4+ T-cell numbers following antibody treatment. However, CD4 expression of individual lamina propria lymphocytes was strongly down-regulated. Depletion of CD4+ T cells performed prior to oral immunization with CT completely inhibited the ability to respond to CT. No antitoxin production, as detected at the single-cell level by the ELISPOT technique, was found in the spleen, mesenteric lymph nodes, or Peyer's patches, nor did we observe serum antitoxin responses in these mice. Control mice demonstrated strong antitoxin responses in all locations following oral immunization with CT. Anti-CD4 antibody treatment also effectively inhibited the antitoxin immunoglobulin A response in the lamina propria to CT as well as blocked the ability to develop gut protection against CT challenge of ligated intestinal loops after oral CT immunization. Thus, in vivo CD4+ T-cell depletion rendered these mice unable to develop protective immunity in the gut following oral immunization with CT. Moreover, CD4+ T-cell depletion effectively inhibited the antitoxin immune response in the gut lamina propria, mesenteric lymph nodes, Peyer's patches, and spleen when performed prior to both priming and booster immunizations with CT. This study clearly demonstrates the requirement of functional CD4+ T cells in the gut immune system for the development of host defense against CT-induced disease. Our data also reinforce the concept of a strong association between gut protection against CT and local production of neutralizing immunoglobulin A antitoxin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1910010      PMCID: PMC258931          DOI: 10.1128/iai.59.10.3630-3638.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Molecular characterization of germ-line immunoglobulin A transcripts produced during transforming growth factor type beta-induced isotype switching.

Authors:  D A Lebman; D Y Nomura; R L Coffman; F D Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

2.  In vivo immunomodulation by monoclonal anti-L3T4. 1. Effects on humoral and cell-mediated immune response.

Authors:  G E Ranges; S M Cooper; S Sriram
Journal:  Cell Immunol       Date:  1987-04-15       Impact factor: 4.868

3.  Protection against experimental cholera in the rat. A study on the formation of antibodies against cholera toxin and desensitization of adenylate cyclase after immunization with cholera toxin.

Authors:  S Lange; I Lönnroth; H Nygren
Journal:  Int Arch Allergy Appl Immunol       Date:  1984

4.  Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.

Authors:  A M Svennerholm; M Jertborn; L Gothefors; A M Karim; D A Sack; J Holmgren
Journal:  J Infect Dis       Date:  1984-06       Impact factor: 5.226

5.  Monoclonal antibodies against rat immunoglobulin kappa chains.

Authors:  L L Lanier; G A Gutman; D E Lewis; S T Griswold; N L Warner
Journal:  Hybridoma       Date:  1982

6.  Cholera antibody production in vitro by peripheral blood lymphocytes following oral immunization of humans and mice.

Authors:  N Lycke; L Lindholm; J Holmgren
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

7.  A sensitive method for the detection of specific antibody production in different isotypes from single lamina propria plasma cells.

Authors:  N Lycke
Journal:  Scand J Immunol       Date:  1986-10       Impact factor: 3.487

8.  In vivo suppression of T-dependent antibody responses by treatment with a monoclonal anti-L3T4 antibody.

Authors:  P G Coulie; J P Coutelier; C Uyttenhove; P Lambotte; J Van Snick
Journal:  Eur J Immunol       Date:  1985-06       Impact factor: 5.532

9.  A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.

Authors:  A Pierres; P Naquet; A Van Agthoven; F Bekkhoucha; F Denizot; Z Mishal; A M Schmitt-Verhulst; M Pierres
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

10.  Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.

Authors:  D Wofsy; W E Seaman
Journal:  J Exp Med       Date:  1985-02-01       Impact factor: 14.307

View more
  13 in total

1.  CD8-deficient mice exhibit augmented mucosal immune responses and intact adjuvant effects to cholera toxin.

Authors:  E Hörnquist; D Grdic; T Mak; N Lycke
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

2.  Adaptive immune responses during Shigella dysenteriae type 1 infection: an in vitro stimulation with 57 kDa major antigenic OMP in the presence of anti-CD3 antibody.

Authors:  Ashim Kumar Bagchi; Ajoy Kumar Sinha; Rushita Adhikari; Joydeep Mukherjee
Journal:  Mol Cell Biochem       Date:  2009-11-14       Impact factor: 3.396

3.  Interferon-gamma receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance.

Authors:  M Kjerrulf; D Grdic; L Ekman; K Schön; M Vajdy; N Y Lycke
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

4.  Intestinal and circulating antibody-forming cells in IgA-deficient individuals after oral cholera vaccination.

Authors:  V Friman; M Quiding; C Czerkinsky; I Nordström; L Larsson; D Ericson; J Björkander; K Theman; A Kilander; J Holmgren
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

5.  Deficient induction of the immune response to oral immunization with cholera toxin in malnourished rats during suckling.

Authors:  J Fló; M E Roux; E Massouh
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

6.  Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: effects in CD4(+) -cell depleted, athymic and NK-cell depleted SCID mice.

Authors:  L G Axelsson; E Landström; T J Goldschmidt; A Grönberg; A C Bylund-Fellenius
Journal:  Inflamm Res       Date:  1996-04       Impact factor: 4.575

7.  Murine intranasal challenge model for the study of Campylobacter pathogenesis and immunity.

Authors:  S Baqar; A L Bourgeois; L A Applebee; A S Mourad; M T Kleinosky; Z Mohran; J R Murphy
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

8.  Monoclonal immunoglobulin A antibodies directed against cholera toxin prevent the toxin-induced chloride secretory response and block toxin binding to intestinal epithelial cells in vitro.

Authors:  F M Apter; W I Lencer; R A Finkelstein; J J Mekalanos; M R Neutra
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

9.  An indispensable role for the chemokine receptor CCR10 in IgA antibody-secreting cell accumulation.

Authors:  Olivier Morteau; Craig Gerard; Bao Lu; Sorina Ghiran; Miriam Rits; Yuko Fujiwara; Yuetching Law; Kathryn Distelhorst; Elizabeth M Nielsen; Erica D Hill; Raymond Kwan; Nicole H Lazarus; Eugene C Butcher; Eric Wilson
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

10.  Immunologic responses to Vibrio cholerae in patients co-infected with intestinal parasites in Bangladesh.

Authors:  Jason B Harris; Michael J Podolsky; Taufiqur R Bhuiyan; Fahima Chowdhury; Ashraful I Khan; Regina C Larocque; Tanya Logvinenko; Jennifer Kendall; Abu S G Faruque; Cathryn R Nagler; Edward T Ryan; Firdausi Qadri; Stephen B Calderwood
Journal:  PLoS Negl Trop Dis       Date:  2009-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.